H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.9% of adults in Houston have diagnosed diabetes — 1.9 points above the U.S. 12% figure. Census population 2,304,580. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Houston clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Houston storefront.
Your Regenerative Medicine Clinic Partner in Houston, TX for clinics & physicians. Partner with Hawk Medic… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 13.9% of adults in Houston have diagnosed diabetes — 1.9 points above the U.S. 12% figure. Census city-proper population is 2,304,580. If you are adding regenerative medicine clinic, start with that epidemiology and with Novitas Solutions (JH) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Your Regenerative Medicine Clinic Partner notes (how the product actually works)CDC PLACES (2023, crude) estimates 13.9% of adults in Houston have diagnosed diabetes — 1.9 points above the U.S. 12% figure. Adult obesity in Houston is 38% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 19.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JH / Novitas Solutions, sibling states AR, CO, LA, MS, NM, OK. Texas DSHS is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, JH articles mapped. 24% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 13.9% of adults — 1.9 points above the U.S. 12% figure. Obesity is 38%; arthritis is 19.3%. That is place-level BRFSS modeling, not a clinic census and not a Houston trial.
Texas is in CMS MAC JH, administered by Novitas Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Point-of-care spin, kit handling, and documentation basics. Injection technique, privileging, and ultrasound guidance remain the clinic’s clinical education path in Texas.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JH reviewers and surveyors expect — not a brochure.
If you operate in Texas and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Houston tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Houston, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Houston is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Houston — 1.9 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Houston. Useful for joint-program math; still needs a diagnosis and privileging.
No Houston storefront. Joe Bradley is an active practice owner. regenerative medicine clinic stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.